ESC Congress 2025
    Sobre el CNIC, Investigación
    EHJ: New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

    The REBOOT study was presented during the European Society of Cardiology Congress (ESC Congress 2025) in Madrid

    Investigación, Publicaciones
    NEJM: A drug used to treat diabetes improves the prognosis of patients undergoing cardiac valve intervention

    The DapaTAVI study, conducted in 39 Spanish hospitals and coordinated by the CNIC, marks a breakthrough in cardiovascular research and could transform the treatment of these patients

    Sobre el CNIC, Investigación
    CNIC joins GRACE, a European project aimed at transforming cardiovascular care through innovation and collaboration

    The CNIC has been allocated €405,625 for its involvement in GRACE, a project focused on developing innovative strategies to improve the detection and management of cardiovascular diseases.


    Anagha Jagannathan, Carlos Real Jiménez, Laura Cádiz, Sofía Trigo Anca, Anabel Díaz-Guerra Priego, Miguel Fernández Tocino, Carlos Galán Arriola, Borja Ibáñez, Agustín Clemente Moragón, Sandra Gomez, Ana Devesa, Juan Rene Delgado Cornejo, Danielle Medina-Hernandez, Warren Alexander Skoza, Lucía Pilar López Palomar, Nico Hoffmann, Carlos Caballero Henares and Ángela Pollán García.
    Investigación, Publicaciones
    JACC CardioOncology: CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

    The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure

    • 2 de 9